2.41
price down icon2.03%   -0.05
after-market After Hours: 2.43 0.02 +0.83%
loading
Nuvation Bio Inc stock is traded at $2.41, with a volume of 3.28M. It is down -2.03% in the last 24 hours and up +23.59% over the past month. Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
See More
Previous Close:
$2.46
Open:
$2.47
24h Volume:
3.28M
Relative Volume:
0.57
Market Cap:
$820.03M
Revenue:
-
Net Income/Loss:
$-75.80M
P/E Ratio:
-6.8857
EPS:
-0.35
Net Cash Flow:
$-68.07M
1W Performance:
-5.86%
1M Performance:
+23.59%
6M Performance:
+0.42%
1Y Performance:
-32.68%
1-Day Range:
Value
$2.35
$2.555
1-Week Range:
Value
$2.35
$2.76
52-Week Range:
Value
$1.54
$3.97

Nuvation Bio Inc Stock (NUVB) Company Profile

Name
Name
Nuvation Bio Inc
Name
Phone
(415) 754-3517
Name
Address
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Name
Employee
273
Name
Twitter
Name
Next Earnings Date
2025-03-05
Name
Latest SEC Filings
Name
NUVB's Discussions on Twitter

Compare NUVB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NUVB
Nuvation Bio Inc
2.41 837.05M 0 -75.80M -68.07M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.16 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.58 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
339.80 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.89 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.94 31.87B 3.81B -644.79M -669.77M -6.24

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-23-25 Initiated Citizens JMP Mkt Outperform
Mar-27-24 Upgrade Jefferies Hold → Buy
Mar-26-24 Upgrade BTIG Research Neutral → Buy
Jan-06-23 Downgrade Jefferies Buy → Hold
Aug-02-22 Downgrade BMO Capital Markets Outperform → Market Perform
Aug-02-22 Downgrade BTIG Research Buy → Neutral
May-04-22 Initiated H.C. Wainwright Buy
Oct-15-21 Resumed BTIG Research Buy
Apr-06-21 Initiated RBC Capital Mkts Outperform
Mar-08-21 Initiated BMO Capital Markets Outperform
Mar-08-21 Initiated BTIG Research Buy
Mar-08-21 Initiated Cowen Outperform
Mar-08-21 Initiated Jefferies Buy
Mar-08-21 Initiated Wedbush Outperform
View All

Nuvation Bio Inc Stock (NUVB) Latest News

pulisher
Jul 28, 2025

What makes Nuvation Bio Inc. stock price move sharplyDaily Smart Money Movement Monitor Activated - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Nuvation Bio (NUVB.N) Surges 8.6% — Unpacking the Intraday Spike Without Fundamentals - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Nuvation Bio Inc. stockStay informed with daily expert analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Nuvation Bio Inc. stock a growth or value playDaily Stock Market Swing Alerts Highlight Key Movers - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How volatile is Nuvation Bio Inc. stock compared to the marketAchieve breakthrough performance with smart picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive Nuvation Bio Inc. stock higher in 2025Discover hidden gems in the stock market - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Will Nuvation Bio Inc. stock benefit from interest rate changesEarly Buy Suggestion - metal.it

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Nuvation Bio Inc. stock priceSuperior stock growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Published on: 2025-07-25 18:05:03 - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025 - BioSpace

Jul 24, 2025
pulisher
Jul 23, 2025

Bullish Nuvation Bio Insiders Loaded Up On US$2.31m Of Stock - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

Is Nuvation Bio Inc. a good long term investmentFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Nuvation Bio Inc. Stock Analysis and ForecastFree Stock Index Interpretation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Nuvation Bio Inc. stockTremendous gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 18, 2025

Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Breakthrough for IDH1 Mutant Glioma - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Is Nuvation Bio Inc. stock a good hedge against inflationFree Investing Community - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Why Nuvation Bio Inc. stock attracts strong analyst attentionLow Risk Entry Points - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Nuvation Bio's Mysterious 5% Surge: A Deep Dive into the Unseen Drivers - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

How Nuvation Bio Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

All You Need to Know About Nuvation Bio (NUVB) Rating Upgrade to Buy - MSN

Jul 11, 2025
pulisher
Jul 10, 2025

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Quantisnow

Jul 10, 2025
pulisher
Jul 09, 2025

Nuvation Bio's 16% Surge: A Deep Dive Into the Unseen Drivers - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Nuvation Bio's 11% Spike: A Deep Dive into the Unseen Drivers - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Nuvation Bio’s 7% Surge: A Technical and Market Flow Deep-Dive - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Nuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Jul 07, 2025
pulisher
Jul 07, 2025

Nuvation Bio’s SWOT analysis: IBTROZI approval boosts stock prospects By Investing.com - Investing.com Nigeria

Jul 07, 2025

Nuvation Bio Inc Stock (NUVB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.55
price up icon 0.23%
$37.12
price down icon 0.40%
$105.18
price up icon 0.17%
$26.66
price down icon 0.30%
$110.05
price down icon 1.28%
biotechnology ONC
$299.94
price down icon 1.90%
Cap:     |  Volume (24h):